Stay updated on Nivolumab for Recurrent Rare CNS Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.2%
    Check dated 2025-05-01T06:11:56.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has updated its date information, adding new dates in April 2025 while removing older dates from early April 2025.
    Difference
    0.2%
    Check dated 2025-04-23T23:35:43.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has undergone significant content changes, including the removal of extensive background information on central nervous system tumors and the addition of specific tumor types and a new version revision number.
    Difference
    59%
    Check dated 2025-04-16T20:22:45.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4 and has added new dates for April 2025 while removing older dates from March 2025.
    Difference
    0.4%
    Check dated 2025-04-09T11:54:50.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.2 to v2.14.3 and changed the date from March 6, 2025, to March 18, 2025.
    Difference
    0.2%
    Check dated 2025-04-02T00:06:09.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The web page has updated the terminology from 'participants' to 'individuals' and made clarifications regarding eligibility criteria and treatment protocols for a study involving nivolumab. Additionally, the page now includes specific details about monitoring and testing procedures post-treatment.
    Difference
    3%
    Check dated 2025-03-25T14:54:48.000Z thumbnail image

Stay in the know with updates to Nivolumab for Recurrent Rare CNS Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.